arrow
C

Charu Gupta

Hannover Medical School
H指数:12
被引数:959

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

tremelimumab联合durvalumab治疗不可切除肝细胞癌的III期喜马拉雅研究的四年总生存期更新

2024-05-0139
OA
Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer)

喜马拉雅研究的简明语言摘要: tremelimumab和durvalumab治疗不可切除的肝细胞癌 (肝癌)

2023-09-0615
OA
drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia (vol 34, pg 2951, 2020)

通过在慢性粒细胞单核细胞白血病的可移植患者来源的异种移植模型中体内筛选确定的药物治疗 (第34卷,2951页,2020)

LEUKEMIA
IF13.4
2021-11-020
OAAI
Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia
LEUKEMIA
IF13.4
2020-06-2413
OAAI